Health

News Hour: The U.S. Food and Drug Administration has granted priority review for Roche drug Lucentis for treating myopic choroidal neovascularization (mCNV), the Swiss drugmaker said on Tuesday, reports Reuters. The ailment is a complication of...

Global health organization PATH and local NGO SERAC-Bangladesh joined together to highlight the fact that many Bangladeshi women lack access to the life-saving medicines that can prevent the two leading causes of death during pregnancy and...

News Hour: Exelixis’s drug Cabometyx outperformed Pfizer’s Sutent in a clinical study for the treatment of metastatic kidney cancer, suggesting it has the potential to become a first-line treatment, researchers said on Monday. The drug is...

News Hour: Evelyn O’Flynn still has lung cancer. But after going straight on to a new immune system-boosting drug more than a year ago, rather than traditional hard-to-tolerate chemotherapy, she is feeling great. “It’s like a...

News Hour: Patients arrived every 10 or 15 minutes, brought on motorcycles by relatives with vomit-covered shoulders and hoisted up the stairs into southwest Haiti’s Port-a-Piment hospital, where they could rest their weak, cholera-sapped limbs. Less...

News Hour: An experimental Novartis pill given with an older drug kept advanced breast cancer in check far longer than standard treatment alone, putting it on track to challenge Pfizer’s blockbuster Ibrance, data showed on Saturday....

News Hour: Cholera has killed at least 13 people in southwest Haiti in the wake of Hurricane Matthew, officials said on Saturday, as government teams fanned out across the hard-hit southwestern tip of the country to...

News Hour: The theme of 2017 World Health Day campaign is depression. Depression affects people of all ages, from all walks of life, in all countries. It causes mental anguish and impacts on people’s ability to...

News Hour: JCI Dhaka Central organized the 4th General Members’ Meeting at Galesia Hotel and Resort in Dhaka, Bangladesh yesterday. This was the last GMM for the year 2016. An overview of all the activities carried...

News Hour: The failure of Bristol-Myers Squibb’s blockbuster Opdivo immunotherapy in previously untreated lung cancer patients has opened up the market for AstraZeneca, its chief executive believes. “Suddenly, this trial news opens quite some opportunities for...